Skip to main content
Clinical Trials/NCT04476082
NCT04476082
Completed
Not Applicable

Analysis of Nutritional Status in Patients With Malignant Tumor Diseases of the Gastrointestinal Tract

University Medicine Greifswald1 site in 1 country66 target enrollmentJune 25, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pancreatic Cancer
Sponsor
University Medicine Greifswald
Enrollment
66
Locations
1
Primary Endpoint
Prevalence of Malnutrition According to the Global Leadership Initiative on Malnutrition criteria (GLIM criteria)
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Malnutrition and loss of muscle mass frequently occur in patients undergoing chemotherapy and can negatively effect therapy outcome. Especially patients with cancer of the gastrointestinal tract are often affected by malnutrition. Therefore, this study aims to examine changes in nutritional status of patients with cancer of the gastrointestinal tract during chemotherapy. Findings of this study will help to improve nutritional treatment of patients undergoing chemotherapy.

Detailed Description

Malnutrition and sarcopenia are common complications in patients with malignant diseases of the gastrointestinal tract. During chemotherapy there is a high risk of further impairment of nutritional status due to anorexia, nausea, emesis and other gastrointestinal conditions that adversely impact food assimilation or absorption. Findings on changes of nutritional status during chemotherapy are scarce but of paramount importance for adequate nutrition therapy. Therefore, this study aims to provide a detailed description of changes in nutritional status of patients with a malignant condition of the gastrointestinal tract during chemotherapy.

Registry
clinicaltrials.gov
Start Date
June 25, 2020
End Date
December 6, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Medicine Greifswald
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with initial diagnosis of a malignant condition of the gastrointestinal tract planned to receive cytostatic treatment.
  • ongoing cytostatic treatment of a known malignant condition of the gastrointestinal tract

Exclusion Criteria

  • pregnancy
  • history of any other malignant tumor disease
  • inability to provide consent

Outcomes

Primary Outcomes

Prevalence of Malnutrition According to the Global Leadership Initiative on Malnutrition criteria (GLIM criteria)

Time Frame: 3 months after study enrollment

Change in prevalence of malnutrition according to the GLIM criteria

Secondary Outcomes

  • Hip Circumference(3 months after study enrollment)
  • Energy Intake(3 months after study enrollment)
  • C-reactive Protein(3 months after study enrollment)
  • Plasma Transcriptome(3 months after study enrollment)
  • Waist Circumference(3 months after study enrollment)
  • Waist-to-Hip Ratio(3 months after study enrollment)
  • Protein Intake(3 months after study enrollment)
  • Carbohydrate Intake(3 months after study enrollment)
  • Physical Activity(3 months after study enrollment)
  • Fat Mass(3 months after study enrollment)
  • Extracellular Water(3 months after study enrollment)
  • Body Mass Index(3 months after study enrollment)
  • Muscle Function(3 months after study enrollment)
  • Dietary Fiber Intake(3 months after study enrollment)
  • Gamma-glutamyl Transferase(3 months after study enrollment)
  • Bilirubin(3 months after study enrollment)
  • Urea(3 months after study enrollment)
  • Plasma Metabolome(3 months after study enrollment)
  • Prevalence of Malnutrition According to the European Society for Clinical Nutrition and Metabolism criteria (ESPEN criteria)(3 months after study enrollment)
  • Fat Free Mass(3 months after study enrollment)
  • Total Body Water(3 months after study enrollment)
  • Phase Angle(3 months after study enrollment)
  • Body Weight(3 months after study enrollment)
  • Height(3 months after study enrollment)
  • Sarcopenia According to the European Working Group on Sarcopenia in Older People 2 criteria (EWGSOP2 criteria)(3 months after study enrollment)
  • Fat Intake(3 months after study enrollment)
  • Albumin(3 months after study enrollment)
  • Alanine Aminotransferase(3 months after study enrollment)
  • Skeletal Muscle Mass(3 months after study enrollment)
  • Upper Arm Circumference(3 months after study enrollment)
  • Triceps Skinfold Thickness(3 months after study enrollment)
  • Muscle Strength(3 months after study enrollment)
  • Complete Blood Count(3 months after study enrollment)
  • Creatinine(3 months after study enrollment)
  • Intestinal Microbiome(3 months after study enrollment)
  • Aspartate Transaminase(3 months after study enrollment)

Study Sites (1)

Loading locations...

Similar Trials